Characterization of recombinant human protein C inhibitor expressed in Escherichia coli
- 1 April 2005
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1748 (1) , 57-65
Abstract
No abstract availableKeywords
Funding Information
- University of North Carolina at Chapel Hill (F32-HL-076108)
- National Institutes of Health (HL-32656, HL-06350, P16093-B04)
This publication has 64 references indexed in Scilit:
- Protective role of activated protein C in lung and airway remodelingCritical Care Medicine, 2004
- Characterization of a novel human protein C inhibitor (PCI) gene transgenic mouse useful for studying the role of PCI in physiological and pathological conditionsJournal of Thrombosis and Haemostasis, 2004
- Inhibition of serine proteases by reactive site mutants of protein C inhibitor (plasminogen activator inhibitor-3)Fibrinolysis and Proteolysis, 1998
- Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human PlasmaBlood, 1998
- Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic systemImmunopharmacology, 1997
- Protein C inhibitor (PCI)Immunopharmacology, 1996
- Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin ComplexJournal of Biological Chemistry, 1995
- Purification and characterization of plasma protein C inhibitorThrombosis Research, 1989
- Protein C inhibitor: Purification and proteinase reactivityThrombosis Research, 1989
- Inactivation of human plasma kallikrein and factor XIa by protein C inhibitorBiochemistry, 1988